U.S. markets closed
  • S&P 500

    4,422.30
    +10.51 (+0.24%)
     
  • Dow 30

    35,144.31
    +82.76 (+0.24%)
     
  • Nasdaq

    14,840.71
    +3.72 (+0.03%)
     
  • Russell 2000

    2,216.92
    +7.27 (+0.33%)
     
  • Crude Oil

    72.18
    +0.11 (+0.15%)
     
  • Gold

    1,798.20
    -3.60 (-0.20%)
     
  • Silver

    25.27
    +0.04 (+0.15%)
     
  • EUR/USD

    1.1808
    +0.0038 (+0.32%)
     
  • 10-Yr Bond

    1.2760
    -0.0100 (-0.78%)
     
  • GBP/USD

    1.3822
    +0.0068 (+0.49%)
     
  • USD/JPY

    110.3800
    -0.1300 (-0.12%)
     
  • BTC-USD

    38,021.24
    +3,622.37 (+10.53%)
     
  • CMC Crypto 200

    903.49
    -12.00 (-1.31%)
     
  • FTSE 100

    7,025.43
    -2.15 (-0.03%)
     
  • Nikkei 225

    27,833.29
    +285.29 (+1.04%)
     

St.Jude Medical adjusted profit rises

Oct 15 (Reuters) - Heart device maker St. Jude Medical Inc reported a lower quarterly profit, as it took a $39 million charge related to impairment and restructuring, despite a rise in sales of its devices to treat abnormal heart rhythms.

Net profit fell to $238 million, or 82 cents per share, for the third quarter ended Sept. 27 from $262 million, or 91 cents per share, a year earlier.

On an adjusted basis, it earned $281 million, or 97 cents per share.

Revenue rose 3 percent to $1.37 billion.

Sales of implantable cardioverter defibrillators and pacemakers, St. Jude's biggest product category, rose 1 percent to $688 million.

(Reporting by Ankur Banerjee in Bangalore)